Helping You Build Wealth With Honest Research
Since 1996. Try Now

MEMBER'S LOGINX

     
Invalid Username / Password
   
     
   
     
 
Invalid Captcha
   
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

GLENMARK PHARMA vs ADCOCK INGRAM (S. Africa) - Comparison Results

ADCOCK INGRAM (S. Africa)
   Change

Adcock Ingram is a leading South African pharmaceutical manufacturer, marketer and distributor. The company occupies 10% share of the private pharmaceutical market in South Africa with a strong presence in over-the-counter (OTC) brands. Adcock is als... More

DO YOU LIKE THESE REPORTS? TELL US!

Financials

 GLENMARK PHARMA   ADCOCK INGRAM
EQUITY SHARE DATA
    GLENMARK PHARMA
Mar-23
ADCOCK INGRAM
Jun-14
GLENMARK PHARMA/
ADCOCK INGRAM
5-Yr Chart
Click to enlarge
High Rs487314-   
Low Rs349226-   
Sales per share (Unadj.) Rs460.493.4-  
Earnings per share (Unadj.) Rs13.4-23.5-  
Cash flow per share (Unadj.) Rs35.0-19.5-  
Dividends per share (Unadj.) Rs2.500-  
Avg Dividend yield %0.60-  
Book value per share (Unadj.) Rs335.173.3-  
Shares outstanding (eoy) m282.17168.78-   
Bonus / Rights / Conversions 00-  
Price / Sales ratio x0.92.9 31.4%   
Avg P/E ratio x31.3-11.5 -272.2%  
P/CF ratio (eoy) x11.9-13.9 -86.1%  
Price / Book Value ratio x1.23.7 33.8%  
Dividend payout %18.70-   
Avg Mkt Cap Rs m117,95345,603 258.7%   
No. of employees `000NA4.3 0.0%   
Total wages/salary Rs m27,8102,862 971.6%   
Avg. sales/employee Rs Th03,671.4-  
Avg. wages/employee Rs Th0666.7-  
Avg. net profit/employee Rs Th0-925.1-  
INCOME DATA
Net Sales Rs m129,90115,761 824.2%  
Other income Rs m3,168110 2,870.2%   
Total revenues Rs m133,06915,872 838.4%   
Gross profit Rs m15,125-2,731 -553.8%  
Depreciation Rs m6,113680 898.6%   
Interest Rs m3,496427 818.8%   
Profit before tax Rs m8,685-3,728 -232.9%   
Minority Interest Rs m0-10 -0.0%   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m4,911233 2,107.9%   
Profit after tax Rs m3,774-3,971 -95.0%  
Gross profit margin %11.6-17.3 -67.2%  
Effective tax rate %56.5-6.2 -904.9%   
Net profit margin %2.9-25.2 -11.5%  
BALANCE SHEET DATA
Current assets Rs m98,73711,544 855.3%   
Current liabilities Rs m50,4556,495 776.8%   
Net working cap to sales %37.232.0 116.0%  
Current ratio x2.01.8 110.1%  
Inventory Days Days7111 6.0%  
Debtors Days Days115124 92.9%  
Net fixed assets Rs m76,9206,729 1,143.1%   
Share capital Rs m28273 385.6%   
"Free" reserves Rs m94,2810-   
Net worth Rs m94,56312,371 764.4%   
Long term debt Rs m38,5214,347 886.1%   
Total assets Rs m175,65823,369 751.7%  
Interest coverage x3.5-7.7 -45.1%   
Debt to equity ratio x0.40.4 115.9%  
Sales to assets ratio x0.70.7 109.6%   
Return on assets %4.1-15.2 -27.3%  
Return on equity %4.0-32.1 -12.4%  
Return on capital %9.2-19.8 -46.2%  
Exports to sales %00-   
Imports to sales %00-   
Net fx Rs m33,7510-   
CASH FLOW
From Operations Rs m6,2541,345 464.9%  
From Investments Rs m-5,285-413 1,279.4%  
From Financial Activity Rs m-7753,945 -19.6%  
Net Cashflow Rs m3254,878 6.7%  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster
The reporting currency for ADCOCK INGRAM (S. Africa) is South Africa Rand. All data has been converted at 4.33 Rs / ZAR

Compare GLENMARK PHARMA With: ACTAVIS (US)  MYLAN (US)  TEVA PHARMA (Israel)  

Compare GLENMARK PHARMA With: NECTAR LIFESCIENCE  INDOCO REMEDIES  COLINZ LABOR  KREBS BIOCHEMICALS  WANBURY  



Today's Market

Sensex Today Trades Flat | Nifty Below 22,350 | Kotak Mahindra Bank Tanks 9% Sensex Today Trades Flat | Nifty Below 22,350 | Kotak Mahindra Bank Tanks 9%(10:30 am)

Asian stocks fell on Thursday as disappointing earnings forecasts from Facebook parent Meta Platforms hammered tech shares, while the yen's slump past 155 per dollar.